Research programme: obesity therapy - Rheoscience
Alternative Names: RHS-02; RHS-03; RHS-08; RHS-12Latest Information Update: 16 Jul 2016
At a glance
- Originator Rheoscience
- Class Small molecules
- Mechanism of Action Neuropeptide Y2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Obesity in Denmark
- 06 Aug 2007 Preclinical trials in Obesity in Denmark (unspecified route)